title: Cytomegalovirus retinitis during immunotherapy for common variable immunodeficiency.
authors.forename: K
authors.initials: K
authors.lastname: Ishikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Ando
authors.forename: M
authors.initials: M
authors.lastname: Narita
authors.forename: M
authors.initials: M
authors.lastname: Shinjoh
authors.forename: T
authors.initials: T
authors.lastname: Iwasaki
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000188:drug therapy; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D017074:Common Variable Immunodeficiency / Q000150:complications*; D003587:Cytomegalovirus / Q000302:isolation & purification*; D017726:Cytomegalovirus Retinitis / Q000139:chemically induced* / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy; D018655:Lymphocyte Count; D008297:Male; D013256:Steroids
chemical_list: D000893:Anti-Inflammatory Agents; D013256:Steroids